These results reveal for the first time that FGF13-AS1 functions as a tumor suppressor by inhibiting glycolysis and sternness properties of breast cancer cells, and the FGF13-AS1/IGF2BPs/Myc feedback loop could be a novel therapeutic target for breast cancer patients.Ma, FeiLiu, XuZhou, ...